NASDAQ:SCNI | Cash Flow Statement | Scinai Immunotherapeutics Ltd.

Complete source-backed cash-flow history.

Available history
2021-12-31 to 2025-12-31
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2023-03-31-$3.52M$138,000.00-$3.06M$6,000.00-$6,000.00
2022-03-31-$2.48M$134,000.00-$1.11M$521,000.00-$521,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$8.31M-$6.03M$24,000.00-$24,000.00$5.77M
2024-12-31$4.8M-$6.34M$12,000.00-$12,000.00$3.44M
2023-12-31-$6.5M$514,000.00-$9.38M$637,000.00-$637,000.00$1.09M
2022-12-31-$5.8M$562,000.00-$7.27M$836,000.00-$836,000.00$6.78M
2021-12-31-$8.21M$471,000.00-$7.43M$139,000.00-$139,000.00$21.43M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.